DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Aschner P, Kipnes MS, Lunceford JK. et al.
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on
glycemic control in patients with type 2 diabetes.
Diabetes Care 2006;
29: 2632-2637
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.